| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |